{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-013067","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.566411+00:00","generated_at":"2026-06-12T07:27:23.965563+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"IRADIMED reports record Q2 revenue of $16.1M, raises FY2023 guidance","bullets":["Q2 revenue $16.1M (+25% YoY); GAAP diluted EPS $0.33 vs $0.26; non-GAAP EPS $0.36 vs $0.26.","Operating income $5.0M, up 19% YoY; 8th consecutive record revenue quarter.","Monitoring devices revenue grew 25% YoY to $6.1M; IV pump systems up 17% to $4.5M.","FY2023 guidance raised: rev $64.5-$65.5M, GAAP EPS $1.25-$1.28, non-GAAP EPS $1.37-$1.40.","Q3 2023 guidance: rev $16.1-$16.3M, GAAP EPS $0.33-$0.35, non-GAAP EPS $0.36-$0.38."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-013067","json":"https://secwatch.observer/filing/0001558370-23-013067.json","markdown":"https://secwatch.observer/filing/0001558370-23-013067.md","text":"https://secwatch.observer/filing/0001558370-23-013067.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023013067/0001558370-23-013067-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023013067/irmd-20230803x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T07:27:23.965563+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ec7cae4082a602dc6c94c0d17cc45f640d8242ee","claim":"IRADIMED CORP reported second quarter ended June 30, 2023 results: revenue $16.1 million, net income $4.2 million, EPS $0.33 per diluted share. Guidance raised.","evidence_excerpt":"For the second quarter ended June 30, 2023, the Company reported over 25% year-over-year revenue growth to $16.1 million compared to $12.7 million for the second quarter of 2022. Net income was $4.2 million, or $0.33 per diluted share, compared to $3.2 million, or $0.26 per diluted share for the second quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023013067/0001558370-23-013067-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$16.1 million"},{"label":"Net income","value":"$4.2 million"},{"label":"EPS","value":"$0.33 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}